News

Mindcure

What’s Going On with MINDCURE?

After an internal strategic review, Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) announced that it is shutting down after determining it can’t raise the money it needs to continue operating. The stock halted trading when the news was released yesterday but later resumed and fell by 38%. The company said it will cut all […]

Numinus To Follow TSX Upgrade with US Listing in 2022 – CEO

Numinus Wellness [TSX:NUMI], a Vancouver-based psychedelic drug research firm with a network of Canadian ketamine-therapy clinics, plans to follow its December 16 listing on the main Toronto Stock Exchange (TSX) with a listing on a US exchange in 2022, said Numinus CEO and founder, Payton Nyquvest. “We are aiming to list on a major US […]

Is This the End of Patents on Psilocybin?

COMPASS Pathways (CMPS)—a leader in the emerging psychedelic therapies space—got dealt a huge blow last week as one of its patents for lab-created psilocybin was formally called into question. On December 15, nonprofit organization Freedom to Operate (FTO) filed a petition essentially claiming that the company’s synthetic psilocybin isn’t a new invention, and therefore can’t […]

Vine Ventures

A New Cross-Sector Partnership Means a Huge Step Forward for MDMA Therapy

A for-profit corporation and a non-profit organization are teaming up to help bring MDMA-assisted therapy to PTSD patients… Health and wellness fund Vine Ventures and the Multidisciplinary Association for Psychedelic Studies (MAPS) announced that they’re co-creating a special purpose vehicle (SPV). The SPV, which will be called the Regenerative Financing Vine (RFV), will have the […]